Myomo, Inc.(MYO)
Health Care Equipment
Orthopedic Implants & Devices
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | KIRK THOMAS F Director | Purchase | +40,002 | +6.44%661,501 | $1.27 | $50,803 | View SEC filing | |
| 2026-06-08 | Mitchell Micah Chief Commercial Officer | Sale | -90,231 | -45.18%109,478 | $0.86 | $77,689 | View SEC filing | |
| 2026-06-01 | KIRK THOMAS F Director | Purchase | +25,000 | +4.19%621,499 | $0.99 | $24,825 | View SEC filing | |
| 2026-05-28 | Kovelman Harry Chief Medical Officer | Sale | -32,000 | -22.76%108,618 | $1.01 | $32,239 | View SEC filing | |
| 2026-05-18 | Manko Joseph M. Jr. Director | Purchase | +201,197 | +9.54%2,309,775 | $0.86 | $173,908 | View SEC filing | |
| 2026-05-18 | KIRK THOMAS F Director | Purchase | +75,006 | +14.38%596,499 | $0.91 | $68,243 | View SEC filing | |
| 2026-05-15 | Mitchell Micah Chief Commercial Officer | Sale | -90,231 | -45.18%109,478 | $0.86 | $77,689 | View SEC filing | |
| 2026-03-17 | Getz Heather C Director | Purchase | +20,000 | +25.31%99,026 | $0.70 | $13,972 | View SEC filing | |
| 2026-03-16 | KIRK THOMAS F Director | Purchase | +72,000 | +16.02%521,493 | $0.71 | $51,113 | View SEC filing | |
| 2026-03-12 | Getz Heather C Director | Purchase | +70,000 | +775.54%79,026 | $0.73 | $50,960 | View SEC filing | |
| 2025-11-24 | KIRK THOMAS F Director | Purchase | +7,437 | +1.68%449,493 | $0.72 | $5,355 | View SEC filing | |
| 2025-11-21 | Crowley Thomas Aloysius Jr. Director | Purchase | +4,385 | +11.15%43,717 | $0.74 | $3,233 | View SEC filing | |
| 2025-08-26 | KIRK THOMAS F Director | Purchase | +50,000 | +12.75%442,056 | $1.15 | $57,500 | View SEC filing | |
| 2025-08-19 | KIRK THOMAS F Director | Purchase | +50,000 | +14.62%392,056 | $1.10 | $55,000 | View SEC filing | |
| 2025-08-18 | GUDONIS PAUL R Chief Executive Officer | Purchase | +50,000 | +6.25%849,545 | $0.95 | $47,295 | View SEC filing | |
| 2025-05-15 | KIRK THOMAS F Director | Purchase | +38,767 | +12.78%342,056 | $3.25 | $125,993 | View SEC filing | |
| 2025-05-15 | GUDONIS PAUL R Chief Executive Officer | Purchase | +30,000 | +3.90%799,545 | $3.22 | $96,612 | View SEC filing | |
| 2025-05-14 | KIRK THOMAS F Director | Purchase | +50,000 | +19.74%303,289 | $3.35 | $167,500 | View SEC filing | |
| 2025-03-21 | Mitchell Micah Chief Commercial Officer | Sale | -48,000 | -25.50%140,269 | $5.16 | $247,565 | View SEC filing | |
| 2025-03-14 | KIRK THOMAS F Director | Purchase | +7,400 | +2.98%255,933 | $5.00 | $37,000 | View SEC filing | |
| 2025-03-14 | Mitchell Micah Chief Commercial Officer | Sale | -48,000 | -25.45%140,572 | $5.16 | $247,565 | View SEC filing | |
| 2025-03-14 | Mitchell Micah Chief Commercial Officer | Sale | -48,000 | -25.45%140,572 | $5.16 | $247,565 | View SEC filing | |
| 2025-03-13 | Kovelman Harry Chief Medical Officer | Sale | -30,000 | -23.72%96,477 | $5.50 | $165,018 | View SEC filing | |
| 2024-09-09 | Kovelman Harry Chief Medical Officer | Sale | -6,700 | -5.14%123,556 | $3.76 | $25,183 | View SEC filing | |
| 2024-09-05 | Kovelman Harry Chief Medical Officer | Sale | -2,029 | -1.53%130,256 | $4.01 | $8,140 | View SEC filing |
1-25 of 59